Skip to content

Venom Ventures Fund invests $5 million in Everscale to address Web3 scalability issues

Venom Ventures Fund invests $5 million in Everscale to address Web3 scalability issues

Venom Ventures Fund, a Web3 and blockchain innovation fund managed by Abu Dhabi-based investment fund manager Iceberg Capital Limited, has announced a collaboration with Everscale, a leading blockchain that intends to address the Web3 industry’s scalability problems. 

A $5 million investment from Venom Ventures Fund will allow Everscale to hire more blockchain developers and take on more projects, according to information shared with Finbold on January 31. 

In the last two years, Everscale has worked tirelessly to grow its presence in Asia by integrating technological solutions and fostering a vibrant community there. Its adaptive sharding technique allows it to adapt effectively to shifting workloads, making it a straightforward and practical alternative for developing large-scale Web3 applications. 

Venom’s strategic investment 

Notably, Venom is the first Layer-1 blockchain to be formally approved and regulated by the Abu Dhabi Global Market (ADGM). Iceberg Capital Limited developed the Venom Ventures Fund in collaboration with Venom Foundation.

Venom Ventures Fund Chairman Peter Knez, ex-CIO of BlackRock, stated:

“For us, this is a strategic investment aimed at the technological development of projects and teams around technologies that we focus on and actively develop. In particular, we are talking about the Venom blockchain project and its ecosystem, which is planned to be launched soon and for which Everscale is a potential Layer 2 solution.”

With the combined efforts of the Venom and Everscale teams, blockchain technology will be brought one step closer to mainstream commercial applications. Payment solutions that include crypto-to-fiat gateways, crypto asset tokenization platforms, and a comprehensive framework for central bank digital currencies (CBDCs)  and stablecoins are all promising areas of ongoing work. 

An Everscale Foundation board member, Moon Young Lee, commented on the investment, stating:

“The technological capabilities of Everscale are immense but they have been underappreciated by a wider audience. Now, Everscale will be able to operate as an experimental network where updates and complex technical solutions can be introduced before they are brought to Venom.” 

Venom was designed as a network of blockchains. Therefore, there is no restriction to the number of additional auxiliary networks at the Layer 2 level nor to the sort of economy or operation at the Layer 2 level. Because of this design, broad adoption of the Venom blockchain is now possible.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.